Novel prognostic indicator combining inflammatory indicators and tumor markers for gastric cancer
Authors:
Open Access
- 18 February 2023
- journal article
- research article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 21 (1) , 1-15
Abstract
Background: Gastric cancer (GC) is one of the most common malignant tumors worldwide, and we hope to identify an economical but practical prognostic indicator. It has been reported that inflammatory indicators and tumor markers are associated with GC progression and are widely used to predict prognosis. However, existing prognostic models do not comprehensively analyze these predictors. Methods: This study retrospectively reviewed 893 consecutive patients who underwent curative gastrectomy from January 1, 2012, to December 31, 2015, in the Second Hospital of Anhui Medical University. Prognostic factors predicting overall survival (OS) were analyzed using univariate and multivariate Cox regression analyses. Nomograms including independent prognostic factors were plotted for predicting survival. Results: Ultimately, 425 patients were enrolled in this study. Multivariate analyses demonstrated that the neutrophil-to-lymphocyte ratio (NLR, total neutrophil count/lymphocyte count × 100%) and CA19-9 were independent prognostic factors for OS (p=0.001, p=0.016). The NLR-CA19-9 score (NCS) is constructed as the combination of the NLR and CA19-9. We defined NLR37 U/ml as an NCS 1, and NLR≥2.46 and CA19-9>37 U/ml as an NCS of 2. The results showed that higher NCS was significantly associated with worse clinicopathological characteristics and OS (ppp<0.001, HR=3.052, 95% CI=1.928–4.832). Compared with traditional predictive indices, the NCS had the highest AUC for a 12-month survival, a 36-month survival, a 60-month survival, and OS (AUC= 0.654, 0.730, 0.811, 0.803, respectively). The nomogram had a higher Harrell’s C-index than the TNM stage alone (0.788 vs. 0.743). Conclusions: The NCS provides more accurate predictions of the prognosis of GC patients, and its predictive value is significantly better than that of traditional inflammatory indicators or tumor markers. It is an effective complement to existing GC assessment systems.Keywords
All Related Versions
Funding Information
- the 2019 Provincial Key Laboratory of Medical Physics and Technology Safety and Security Open Fund (LMPT201908)
- he role of microbial-gut-brain axis in laparoscopic sleeve gastrectomy on cognitive function of fat patients and related mechanisms (2020LCZD07)
- Study of environmental pathogenic factors and mechanisms of metabolic diseases Research (2021lcxk033)
This publication has 37 references indexed in Scilit:
- The Complex Role of Neutrophils in Tumor Angiogenesis and MetastasisCancer Immunology Research, 2016
- Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic testsBMJ, 2016
- Analysis of the Fibrinogen and Neutrophil–Lymphocyte Ratio in Esophageal Squamous Cell CarcinomaMedicine, 2015
- Neutrophils: important contributors to tumor progression and metastasisCancer and Metastasis Reviews, 2015
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trialThe Lancet Oncology, 2014
- Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastric carcinomaThe American Journal of Surgery, 2011
- Gastric Cancer Working Group ReportJapanese Journal of Clinical Oncology, 2010
- Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratioThe American Journal of Surgery, 2010
- Cancer-related inflammationNature, 2008
- Inflammation and cancer: back to Virchow?The Lancet, 2001